CLO buyers seeking longer duration product have a new three-year reinvestment deal from BlackRock to look forward to next week, and it's the second of its kind in the U.S. since the pandemic struck.
The $400 million BSL CLO for BlackRock via Goldman Sachs is slated for Thursday, according to marketing materials reviewed by AlternativesWatch. Investors in CLO new issues have expressed frustration that only PGIM has issued a transaction with a longer than one-year reinvestment period.
Longer reinvestment periods are a hurdle for . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
